Star Imaging and Path Lab Limited
BSE: STARIMAGIN · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Star Imaging and Path Lab Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Star Imaging and Path Lab Limited is a New Delhi-based healthcare provider specialising in diagnostic and pathology services. The company operates a network of centres offering radiology, MRI, CT scans, and comprehensive laboratory investigations.
Business Model
The company generates revenue by providing diagnostic and pathology services to both walk-in retail customers and corporate clients. It leverages advanced medical technology and standardised reporting to support clinical decision-making.
Management Commentary
Management is focused on expanding the company's geographical footprint and service portfolio to meet the rising demand for preventive healthcare.
Growth Outlook
Growth is driven by the increasing demand for specialised diagnostics and preventive healthcare services across North India. The company aims to scale its network and enhance its service offerings to capture a larger market share.
Key Risks
- Regulatory Compliance. The diagnostic sector is subject to stringent healthcare regulations and quality standards that require continuous compliance.
- Intense Competition. The company faces significant competition from both large national diagnostic chains and numerous local unorganised players.
- Technological Obsolescence. Rapid advancements in medical diagnostic equipment necessitate frequent capital expenditure to maintain service quality and relevance.
- Geographic Concentration. As a regional player focused on North India, the company is susceptible to localised economic downturns or regional market saturation.
Start your research today
Unlock AI insights, financials, peers and live data on Star Imaging and Path Lab Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Star Imaging and Path Lab LimitedSTARIMAGIN | ₹133 Cr | — | — | — | 39.0% | — | — | -43.6% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,851 Cr | 50.02 | 17.47 | 22.5% | 32.7% | 15.8% | 18.6% | +17.7% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,817 Cr | 18.46 | 8.75 | 10.2% | 32.5% | 10.5% | 13.3% | -28.2% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,229 Cr | 25.08 | 14.76 | 54.3% | 52.8% | 19.0% | 24.1% | +18.1% |
One Global Service Provider LimitedONEGLOBAL | ₹1,062 Cr | 13.88 | 10.52 | 161.6% | 19.4% | 69.4% | 92.5% | +93.2% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹857 Cr | — | — | — | 36.0% | — | — | — |
As of Mar 2026
Financials
Star Imaging and Path Lab Limited
BSE: STARIMAGIN · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Star Imaging and Path Lab Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Star Imaging and Path Lab Limited is a New Delhi-based healthcare provider specialising in diagnostic and pathology services. The company operates a network of centres offering radiology, MRI, CT scans, and comprehensive laboratory investigations.
Business Model
The company generates revenue by providing diagnostic and pathology services to both walk-in retail customers and corporate clients. It leverages advanced medical technology and standardised reporting to support clinical decision-making.
Management Commentary
Management is focused on expanding the company's geographical footprint and service portfolio to meet the rising demand for preventive healthcare.
Growth Outlook
Growth is driven by the increasing demand for specialised diagnostics and preventive healthcare services across North India. The company aims to scale its network and enhance its service offerings to capture a larger market share.
Key Risks
- Regulatory Compliance. The diagnostic sector is subject to stringent healthcare regulations and quality standards that require continuous compliance.
- Intense Competition. The company faces significant competition from both large national diagnostic chains and numerous local unorganised players.
- Technological Obsolescence. Rapid advancements in medical diagnostic equipment necessitate frequent capital expenditure to maintain service quality and relevance.
- Geographic Concentration. As a regional player focused on North India, the company is susceptible to localised economic downturns or regional market saturation.
Start your research today
Unlock AI insights, financials, peers and live data on Star Imaging and Path Lab Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026